|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
56,296,000 |
Market
Cap: |
230.81(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$2.07 - $5.65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics initially for cancer and autoimmune disorders. Co.'s two product candidates are wholly owned: STRO-001, an antibody-drug conjugates (ADC) directed against CD74, for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
12,185 |
39,226 |
39,226 |
Total Sell Value |
$0 |
$60,925 |
$186,802 |
$186,802 |
Total People Sold |
0 |
1 |
2 |
2 |
Total Sell Transactions |
0 |
1 |
3 |
3 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Srinivasan Venkatesh |
CHIEF TECH OP OFFICER |
|
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
18,503 |
|
- |
|
Chung Jane |
PRESIDENT AND COO |
|
2024-03-01 |
4 |
D |
$4.95 |
$10,088 |
D/D |
(2,038) |
36,535 |
|
- |
|
Chung Jane |
PRESIDENT AND COO |
|
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
38,573 |
|
- |
|
Borgman Anne Elizabeth |
CHIEF MEDICAL OFFICER |
|
2024-02-29 |
4 |
D |
$4.91 |
$64,449 |
D/D |
(13,126) |
24,374 |
|
- |
|
Borgman Anne Elizabeth |
CHIEF MEDICAL OFFICER |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
37,500 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2024-01-29 |
4 |
D |
$4.99 |
$16,866 |
D/D |
(3,380) |
57,560 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
60,940 |
|
- |
|
Vasquez Nicki |
CHIEF PORT. STRAT & ALNCE OFCR |
|
2024-01-29 |
4 |
D |
$4.99 |
$5,110 |
D/D |
(1,024) |
14,279 |
|
- |
|
Vasquez Nicki |
CHIEF PORT. STRAT & ALNCE OFCR |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
15,303 |
|
- |
|
Vasquez Nicki |
CHIEF PORT. STRAT & ALNCE OFCR |
|
2024-01-29 |
4 |
AS |
$5.00 |
$60,925 |
D/D |
(12,185) |
12,803 |
|
-15% |
|
Newell William J |
CEO |
|
2024-01-29 |
4 |
D |
$4.99 |
$28,114 |
D/D |
(5,634) |
172,932 |
|
- |
|
Newell William J |
CEO |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
178,566 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2024-01-29 |
4 |
D |
$4.99 |
$10,733 |
D/D |
(2,151) |
90,792 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
92,943 |
|
- |
|
Shtylla Brunilda |
Chief Business Officer |
|
2023-08-28 |
4 |
S |
$4.71 |
$72,595 |
D/D |
(15,428) |
0 |
|
26% |
|
Shtylla Brunilda |
Chief Business Officer |
|
2023-08-25 |
4 |
S |
$4.59 |
$53,282 |
D/D |
(11,613) |
12,928 |
|
3% |
|
Chung Jane |
Chief Commercial Officer |
|
2023-08-09 |
4 |
D |
$4.22 |
$27,358 |
D/D |
(6,483) |
31,698 |
|
- |
|
Chung Jane |
Chief Commercial Officer |
|
2023-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
38,181 |
|
- |
|
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
|
2023-07-12 |
4 |
D |
$4.70 |
$5,278 |
D/D |
(1,123) |
24,988 |
|
- |
|
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
|
2023-07-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,250 |
26,111 |
|
- |
|
Petree Daniel H |
Director |
|
2023-06-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
18,409 |
18,601 |
|
- |
|
Petree Daniel H |
Director |
|
2023-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,409 |
3,856 |
|
- |
|
Srinivasan Venkatesh |
Chief Tech Op OfficerOfficer |
|
2023-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,503 |
|
-1% |
|
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
|
2023-04-14 |
4 |
D |
$4.40 |
$5,702 |
D/D |
(1,296) |
100,368 |
|
- |
|
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
|
2023-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
101,664 |
|
- |
|
221 Records found
|
|
Page 2 of 9 |
|
|